ArticlePLoS pathogens2026
Peptidoglycan architecture dictates protein interactions, tissue tropism, and arthritis in the Lyme disease spirochete Borrelia burgdorferi.
Article in PLoS pathogens, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Lyme disease is a vector-borne illness transmitted by infected Ixodes spp. ticks. Dissemination of the Lyme spirochete-Borrelia burgdorferi-from the tick bite site results in a bi-phasic infection; the latter phase can cause severe musculoskeletal disease including arthritis. Lyme arthritis is an inflammatory disorder and maladaptive immune response to B. burgdorferi infection and its cellular products. One such product, which has been implicated as a key mediator of Lyme arthritis, is peptidoglycan. Peptidoglycan (PG) is a near ubiquitous feature of the bacterial cell envelope, but several chemical features make B. burgdorferi PG distinct from other members of the kingdom. We hypothesized the overall chemical composition and structural architecture of the B. burgdorferi cell wall are essential to Lyme disease pathogenesis. To manipulate the PG peptide chemical composition, as well as the native cross-links, we produced an isogenic deletion of a putative PG carboxypeptidase dacA homologue and assessed both the molecular and cellular phenotypes while probing the pathogenicity of our mutant strain. Our combined and comprehensive approach indicates while changes to PG stem peptide and cross-linking have virtually no discernable impact on any B. burgdorferi characteristic in vitro, alterations have significant impacts on tissue tropism and result in a near complete attenuation of Lyme arthritis. PG sacculi containing increased amounts of free and cross-linked pentapeptide surprisingly caused the disassociation of p83/100, an abundant periplasmic protein of unknown function previously implicated in joint tropism, likely contributing to a marked decrease in pathogenicity. These studies strengthen our understanding of the B. burgdorferi cell envelope, its unusual components, and further define bacterial features that mediate infectious arthritis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.